IGFBP3 and breast cancer: Through a combination of in vitro experiments, clinical analyses and assessment of data from the publicly available METABRIC gene expression database, we have provided evidence that the interaction between GRP78 and IGFBP-3 plays major role in breast cancer progression and prognosis.